Pertussis vaccine is a vaccine that protects against whooping cough. There are two main types: whole-cell vaccines and acellular vaccines. The whole-cell vaccine is about 78% effective while the acellular vaccine is 71–85% effective.
Published by: GIR (GlobalInfoResearch)
Catalog: Pharma & Healthcare
Publishing Date: Nov 2016
Single User License: USD 3480
Corporate Users License: USD 4680
Delivery time: 24 hours
Pages: 113
Tables and Figures: 134
Full information :[url]http://www.globalinforesearch.com/goods.php?id=1561[url]
Scope of the Report:
This report focuses on the Pertussis Vaccine in Global market, especially in North America, Europe and Asia-Pacific, South America, Middle East and Africa. This report categorizes the market based on manufacturers, regions, type and application.
Market Segment by Manufacturers, this report covers
Sanofi Pasteur
GSK
Mitsubishi Tanabe Pharma
Astellas Pharma
Minhai Biotechnology
Wuhan Institute of
Biological Products
Changchun Changsheng
Life Sciences
Beijing Tiantan
Biological Products
Chengdu Institute of
Biological Products
Market Segment by Regions, regional analysis covers
North America (USA, Canada and Mexico)
Europe (Germany, France, UK, Russia and Italy)
Asia-Pacific (China, Japan, Korea, India and Southeast Asia)
South America, Middle East and Africa
Market Segment by Type, covers
Whole-cell vaccines
Acellular vaccines
Other
Market Segment by Applications, can be divided into
Children
Adults
There are 13 Chapters to deeply display the global Pertussis Vaccine market.
Chapter 1, to describe Pertussis Vaccine Introduction, product scope, market overview, market opportunities, market risk, market driving force;
Chapter 2, to analyze the top manufacturers of Pertussis Vaccine, with sales, revenue, and price of Pertussis Vaccine, in 2015 and 2016;
Chapter 3, to display the competitive situation among the top manufacturers, with sales, revenue and market share in 2015 and 2016;
Chapter 4, to show the global market by regions, with sales, revenue and market share of Pertussis Vaccine, for each region, from 2011 to 2016;
Chapter 5, 6, 7 and 8, to analyze the key regions, with sales, revenue and market share by key countries in these regions;
Chapter 9 and 10, to show the market by type and application, with sales market share and growth rate by type, application, from 2011 to 2016;
Chapter 11, Pertussis Vaccine market forecast, by regions, type and application, with sales and revenue, from 2016 to 2021;
Chapter 12 and 13, to describe Pertussis Vaccine sales channel, distributors, traders, dealers, appendix and data source.
Betty
Sales Director
E-mail:
[email protected]
Tel: HK:00852-58197708 USA:0013479661888
Add: Room 1902 Two International Finance Centre 8 Finance Street, Central Hong Kong
Website: http://www.globalinforesearch.com/goods_all.php